← FDA Drug Approvals (Drugs@FDA)
GAVRETO
NDA · New Drug Application · Sponsor: RIGEL PHARMS · Approved 2020-09-04
Drug application
- FDA Application #
NDA213721- Application type
- New Drug Application
- Brand name
- GAVRETO
- Generic name
- PRALSETINIB
- Active ingredients
- PRALSETINIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RIGEL PHARMS
- Manufacturer
- Genentech, Inc.
- First approval
- 2020-09-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown